Suppr超能文献

探究美国接受药物辅助治疗的青少年完成治疗的决定因素。

Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.

作者信息

Adeniran Esther A, Quinn Megan, Liu Ying, Brooks Billy, Pack Robert P

机构信息

Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN 37614, USA.

出版信息

Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare13070798.

Abstract

BACKGROUND

An effective treatment for Opioid Use Disorder is Medication-Assisted Treatment (MAT). However, in the United States (US), this is still being underutilized by youth. Research indicates the need to develop strategies to reduce treatment barriers among these youth. Thus, we explored the rates of treatment completion and dropout among youth receiving MAT in US substance use treatment facilities and examined factors associated with treatment completion and dropout.

METHODS

This study used the 2019 Treatment Episode Data Set-Discharges. Our analysis was restricted to youth (12-24 years) who primarily used heroin at admission. Log-binomial regression was used to examine various determinants of treatment completion and dropout, guided by Andersen's Behavioral Model.

RESULTS

The final sample size was 4917. Among youth reporting heroin use with receipt of MAT, those showing a higher likelihood of treatment completion than dropout were males [ARR: 1.23; 95% CI: 1.088-1.381; = 0.0008], had 1-7 times [ARR: 1.33; 95% CI: 1.115-1.584; = 0.0015] and 8-30 times self-help group participation [ARR: 1.50; 95% CI: 1.246-1.803; < 0.0001], had co-occurring mental and substance use disorders [ARR: 1.28; 95% CI: 1.133-1.448, < 0.0001], were admitted to detoxification [ARR: 2.80; 95% CI: 2.408-3.255; < 0.0001] and residential/rehabilitation settings [ARR: 2.05; 95% CI: 1.749-2.400; < 0.0001], and were located in the Midwest/West [ARR: 1.18; 95% CI: 1.030-1.358; = 0.0173]. Conversely, other races (excluding Whites and Blacks/African Americans) [ARR: 0.75; 95% CI: 0.609-0.916; = 0.0051], those who used MAT [ARR: 0.81; 95% CI: 0.694-0.946; = 0.0077], and youth in the South [ARR: 0.45; 95% CI: 0.369-0.549; < 0.0001] were less likely to report treatment completion than dropout.

CONCLUSIONS

The majority of youth receiving MAT dropped out of treatment. We identified various factors that should be prioritized to address youth underutilization of MAT in the US.

摘要

背景

药物辅助治疗(MAT)是治疗阿片类物质使用障碍的一种有效方法。然而,在美国,青少年对这种治疗方法的使用率仍然很低。研究表明,有必要制定策略来减少这些青少年的治疗障碍。因此,我们探讨了在美国物质使用治疗机构接受MAT治疗的青少年的治疗完成率和辍学率,并研究了与治疗完成和辍学相关的因素。

方法

本研究使用了2019年治疗事件数据集-出院数据。我们的分析仅限于入院时主要使用海洛因的青少年(12 - 24岁)。在安德森行为模型的指导下,使用对数二项回归来研究治疗完成和辍学的各种决定因素。

结果

最终样本量为4917。在报告使用海洛因并接受MAT治疗的青少年中,治疗完成可能性高于辍学可能性的有男性[风险比(ARR):1.23;95%置信区间(CI):1.088 - 1.381;P = 0.0008],自助小组参与次数为1 - 7次[ARR:1.33;95% CI:1.115 - 1.584;P = 0.0015]和8 - 30次[ARR:1.50;95% CI:1.246 - 1.803;P < 0.0001],同时患有精神和物质使用障碍[ARR:1.28;95% CI:1.133 - 1.448;P < 0.0001],被收治到戒毒所[ARR:2.80;95% CI:2.408 - 3.255;P < 0.0001]和住院/康复机构[ARR:2.05;95% CI:1.749 - 2.400;P < 0.0001],以及位于中西部/西部地区[ARR:1.18;95% CI:1.030 - 1.358;P = 0.0173]。相反,其他种族(不包括白人和黑人/非裔美国人)[ARR:0.75;95% CI:0.609 - 0.916;P = 0.0051]、使用MAT的人[ARR:0.81;95% CI:0.694 - 0.946;P = 0.0077]以及南部地区的青少年[ARR:0.45;95% CI:0.369 - 0.549;P < 0.0001]报告治疗完成的可能性低于辍学可能性。

结论

大多数接受MAT治疗的青少年中途退出了治疗。我们确定了在美国应对青少年对MAT利用不足问题时应优先考虑的各种因素。

相似文献

5
Demographic and Clinical Correlates of Treatment Completion among Older Adults with Heroin and Prescription Opioid Use Disorders.
J Psychoactive Drugs. 2022 Nov-Dec;54(5):440-451. doi: 10.1080/02791072.2021.2009068. Epub 2021 Nov 25.
7
Patient predictors of substance use disorder treatment initiation in primary care.
J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28.
10
Medication-assisted treatment and self-help group participation among military veterans with opioid or alcohol use disorder.
BMJ Mil Health. 2023 Jun;169(3):256-262. doi: 10.1136/bmjmilitary-2021-001845. Epub 2021 Jul 12.

引用本文的文献

本文引用的文献

1
Self-help groups and opioid use disorder treatment: An investigation using a machine learning-assisted robust causal inference framework.
Int J Med Inform. 2024 Oct;190:105530. doi: 10.1016/j.ijmedinf.2024.105530. Epub 2024 Jun 24.
5
A Better Life: Factors that Help and Hinder Entry and Retention in MAT from the Perspective of People in Recovery.
J Appalach Health. 2023 Apr 1;5(1):72-94. doi: 10.13023/jah.0501.06. eCollection 2023.
6
Factors Associated With Indirect Exposure to and Knowledge of Fentanyl Among Youth.
J Adolesc Health. 2024 Feb;74(2):312-319. doi: 10.1016/j.jadohealth.2023.08.040. Epub 2023 Nov 3.
7
A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care.
Drug Alcohol Depend Rep. 2023 Mar 24;7:100152. doi: 10.1016/j.dadr.2023.100152. eCollection 2023 Jun.
8
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
J Subst Use Addict Treat. 2023 Jun;149:209028. doi: 10.1016/j.josat.2023.209028. Epub 2023 Mar 31.
9
Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021.
JAMA. 2022 Apr 12;327(14):1398-1400. doi: 10.1001/jama.2022.2847.
10
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验